Leverage Health, Inc. – Trademark Portfolio

Entity Type: 03

Leverage Health, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 45 (Legal & Security Services) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MIND&MOBILITY. The owner is based in Fort Lauderdale, FL.

719 NE 26th Avenue

Fort Lauderdale, FL 33304

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Leverage Health, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

45
Legal & Security Services (1 filing)

Legal services; security services for the protection of property and individuals

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Leverage Health, Inc. have?

Leverage Health, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Leverage Health, Inc. file in?

Leverage Health, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 45 (Legal & Security Services), Class 44 (Medical Services). Class 45 covers legal services; security services for the protection of property and individuals.

What are Leverage Health, Inc.'s most well-known trademarks?

Leverage Health, Inc.'s registered trademark portfolio includes well-known marks such as MIND&MOBILITY. These are among 1 currently registered trademark in the portfolio.

What is Leverage Health, Inc.'s trademark registration success rate?

Leverage Health, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.